Feasibility of Performing Laparoscopic Completion Staging in Incidentally Diagnosed Early-Stage Ovarian Carcinoma Patients
- 8 Downloads
Laparoscopy has been described as a method for surgical reassessment in patients with ovarian cancer since the early 1970s; however, these early reports were received with limited acceptance of laparoscopy as a replacement for laparotomy. The objective of this study was to assess the feasibility of laparoscopy as an option for completion staging in ovarian carcinoma.
Materials and Methods
A retrospective analysis was performed at our institute from January 2015 till June 2016 of patients who were diagnosed with early ovarian carcinoma incidentally following surgery elsewhere. Completion staging was done laparoscopically.
12 patients had undergone completion staging. The average age was 33 years. Initial biopsy following the first surgery was epithelial ovarian carcinoma in nine patients, granulosa cell tumor in two patients and teratoma in one patient. After the first surgery, CA-125 levels were elevated in two patients. The average duration between the two surgeries was 55 days. Five patients showed residual malignancy after completion staging, of which four (33%) patients were upstaged. The average number of pelvic and para-aortic lymph nodes dissected was 16 and 7 respectively, of which none were positive. Two patients underwent fertility-preserving surgery, preserving the contralateral ovary and uterus. None of the patients required conversion to laparotomy. Postoperative recovery was uneventful in all the patients. Average hospital stay was 4.5 days. Adjuvant chemotherapy was given to six patients.
Completion staging should be considered for patients diagnosed with early ovarian cancer following surgery for undiagnosed adnexal mass. Laparoscopic staging is feasible in such cases without any increase in morbidity.
KeywordsOvarian cancer Laparoscopy Restaging Feasibility
Compliance with ethical standards
Conflict of interest
There was no conflict of interest.
- 1.Chan JK, Tian C, Fleming GF, Monk BJ, Herzog TJ, Kapp DS, et al. The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study. Gynecol Oncol. 2010;116:301–6.CrossRefGoogle Scholar
- 21.Medeiros LR, Rosa DD, Bozzetti MC, et al. Laparoscopy versus laparotomy for FIGO stage I ovarian cancer. Cochrane Database Syst Rev. 2008;2:CD005344.Google Scholar